Advertisement
U.S. markets open in 8 hours 45 minutes

TherapeuticsMD, Inc. (TXMD)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
2.3000-0.1000 (-4.17%)
At close: 04:00PM EDT
2.2700 -0.03 (-1.30%)
After hours: 06:01PM EDT
Advertisement
Show:
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
12/31/2022
12/31/2021
12/31/2020
Total Revenue
69,366
69,963
2,573
64,872
Cost of Revenue
0
1,397
1,402
15,975
Gross Profit
69,366
68,566
1,171
48,897
Operating Expense
18,364
57,903
80,748
204,438
Operating Income
51,002
10,663
-79,577
-155,541
Net Non Operating Interest Income Expense
-
-
-32,917
-28,581
Other Income Expense
-8,592
-9,589
272
598
Pretax Income
42,295
1,074
-79,305
-183,524
Tax Provision
-
0
0
0
Net Income Common Stockholders
68,307
111,997
-172,415
-183,524
Diluted NI Available to Com Stockholders
68,307
111,997
-172,415
-183,524
Basic EPS
7.63
12.41
-21.66
-33.50
Diluted EPS
7.18
11.96
-21.66
-33.50
Basic Average Shares
10,051
9,028
7,960
5,513
Diluted Average Shares
10,389
9,366
7,960
5,513
Total Operating Income as Reported
41,530
1,191
-79,577
-155,541
Total Expenses
18,364
59,300
82,150
220,413
Net Income from Continuing & Discontinued Operation
68,307
111,997
-172,415
-183,524
Normalized Income
49,778
10,546
-79,305
-183,524
Interest Income
0
-
-
-
Interest Expense
-
-
22,568
26,049
Net Interest Income
-
-
-32,917
-28,581
EBIT
51,999
10,663
-79,577
-157,475
EBITDA
52,593
11,856
-78,841
-153,408
Reconciled Cost of Revenue
0
1,397
1,402
15,975
Reconciled Depreciation
594
1,193
736
4,067
Net Income from Continuing Operation Net Minority Interest
42,295
1,074
-79,305
-183,524
Total Unusual Items Excluding Goodwill
-9,472
-9,472
0
0
Total Unusual Items
-9,472
-9,472
0
0
Normalized EBITDA
62,065
21,328
-78,841
-153,408
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
-1,989
0
0
0